Brian Dorsey
CIK 1380762 · Chief Operating Officer · last filed 2026-01-05
Brian Dorsey is a Chief Operating Officer who has filed 56 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for SPRY, was dated Jan 5, 2026. Across all open-market trades the lifetime net is −$2.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $61.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$61.2K
4
56
-$2.70M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRY | Chief Operating Officer | 10,789 | $5.67 | $61.2K | -$1.82M | 8 | 2026-01-05 |
| SEELOS THERAPEUTICS, INC. (APRI) Delisted | SVP, Chief Development Officer | 5,304 | — | — | $10.5K | 13 | 2018-09-04 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | SVP Research | 6,243 | — | — | $0 | 2 | 2014-10-10 |
| Pernix Sleep, Inc. (SOMX) Delisted | SVP, Technical Operations | 52,264 | — | — | -$887.0K | 28 | 2013-01-03 |
Recent Filings
56 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-05 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2025-11-14 | SPRY | Mixed | — | -$176.1K | EDGAR |
| 2025-11-13 | SPRY | Notice (144) | −21,828 | -$190.0K | EDGAR |
| 2025-01-03 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2024-12-13 | SPRY | Mixed | — | -$468.3K | EDGAR |
| 2024-12-11 | SPRY | Notice (144) | −61,200 | -$814.6K | EDGAR |
| 2024-08-21 | SPRY | Mixed | — | -$718.0K | EDGAR |
| 2024-08-20 | SPRY | Notice (144) | −50,000 | -$750.0K | EDGAR |
| 2024-08-15 | SPRY | Mixed | — | -$370.8K | EDGAR |
| 2024-08-13 | SPRY | Notice (144) | −30,000 | -$390.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.